In the basal-like, lymph-node positive group (PAM50), high eEF2 K expression was significantly associated with reduced RFS (HR = 1.85, log-rank p = 0.015), suggesting that eEF2 K may play a role in promoting tumor recurrence in more aggressive forms of breast cancer. The gene discussed is EEF2K; the disease is breast carcinoma.